The autopulse platform (sn (b)(6)) was used on a 76 year old, 102 kg male patient who was coded for a total of 40 minutes.The patient has a history of anemia, a-fib, cad, chf, ckd, copd, colon polyps, diabetes, diabetic neuropathy, gastroparesis, gerd, hyperlipidemia, htn, obesity, pvd, and sleep apnea.The patient was taking acetadote, albuterol, amiodarone, eliquis, lipitor, dulcolax, plavix, digoxin, flonase, lantus, humalog, metoprolol, protonix, zosyn, mirilax, and lyrica.The cardiac arrest was witnessed in-patient, and the patient received manual cpr for approximately 15 minutes, prior to being placed on the platform.The platform was used for the rest of the call without any issues or malfunction.Return of spontaneous circulation (rosc) was successfully achieved, and the patient has full neurological function.However, the patient has a new development of paraplegia and is unable to walk.This symptom was noticed several hours after the event.An mri was performed and confirmed several spinal infarcts.There was a question of this being caused by the platform.
|